Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Jan-22 | Jan-23 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 240 | 262 | 378 | 741 | 1,242 | 927 | 845 | 1,074 | 1,166 | 1,169 | | 1,255 |
% Growth | NA | 9.1% | 44.4% | 96.0% | 67.5% | -25.4% | -8.8% | 27.1% | 8.5% | 0.3% | | |
| | | | | | | | | | | | |
Cost of Revenue | (141) | (152) | (237) | (466) | (798) | (674) | (669) | (836) | (887) | (872) | | (970) |
Gross Profit | 99 | 110 | 141 | 275 | 444 | 252 | 176 | 239 | 279 | 297 | | 285 |
% Revenue | 41.4% | 42.1% | 37.3% | 37.1% | 35.7% | 27.2% | 20.9% | 22.2% | 23.9% | 25.4% | | 22.7% |
| | | | | | | | | | | | |
Research and Development | (11) | (14) | (19) | (33) | (58) | (78) | (69) | (65) | (58) | (75) | | (69) |
Selling and Marketing | (14) | (17) | (22) | (39) | (76) | (101) | (73) | (63) | (111) | (135) | | (164) |
General and Admin | (34) | (35) | (51) | (57) | (93) | (113) | (170) | (116) | (83) | (106) | | (100) |
Other Inc / (Exp) | 11 | 14 | 20 | 6 | 24 | (1,154) | 31 | 27 | 20 | 50 | | 23 |
Total Operating Exp | (47) | (51) | (72) | (124) | (203) | (1,447) | (280) | (218) | (232) | (266) | | (311) |
| | | | | | | | | | | | |
Operating Income | 52 | 59 | 69 | 151 | 241 | (1,194) | (104) | 21 | 47 | 31 | | (26) |
% Revenue | 21.7% | 22.4% | 18.3% | 20.3% | 19.4% | -128.9% | -12.3% | 1.9% | 4.0% | 2.6% | | -2.1% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 2 | (0) | (10) | (15) | 127 | (2) | (7) | (13) | | (14) |
Pre-tax Income | 53 | 59 | 71 | 150 | 231 | (1,209) | 23 | 19 | 40 | 18 | | (40) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (8) | (8) | (11) | (21) | (33) | 6 | 33 | 10 | 7 | 1 | | 2 |
Net Income to Company | 45 | 51 | 61 | 129 | 198 | (1,204) | 56 | 29 | 46 | 19 | | (38) |
% Margin | 18.6% | 19.6% | 16.0% | 17.4% | 16.0% | -129.9% | 6.6% | 2.7% | 4.0% | 1.6% | | -3.1% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 1 | (1) | (4) | (3) | (2) | (1) | 0 | 3 | 2 | 7 | | 8 |
Net Income to Stockholders | 45 | 50 | 56 | 126 | 196 | (1,205) | 56 | 32 | 49 | 26 | | (31) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 45 | 50 | 56 | 126 | 196 | (1,205) | 56 | 32 | 49 | 26 | | (31) |
% Margin | 18.9% | 19.1% | 14.9% | 17.0% | 15.8% | -130.0% | 6.7% | 2.9% | 4.2% | 2.2% | | -2.4% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.11 | 0.12 | 0.11 | 0.17 | 0.22 | (1.36) | 0.06 | 0.04 | 0.06 | 0.03 | | (0.04) |
Diluted EPS (Continuing Ops) | 0.11 | 0.12 | 0.11 | 0.17 | 0.22 | (1.36) | 0.06 | 0.04 | 0.06 | 0.03 | | (0.04) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 401.30 | 405.90 | 511.03 | 741.76 | 891.51 | 887.23 | 882.69 | 827.59 | 828.34 | 828.12 | | 827.59 |
WA Diluted Shares Out. | 401.30 | 405.90 | 511.03 | 741.76 | 891.51 | 887.23 | 882.69 | 827.59 | 828.34 | 828.12 | | 827.59 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 53 | 59 | 71 | 150 | 231 | (1,209) | 23 | 19 | 40 | 18 | | (40) |
Addback: Net Interest Expense | (0) | (0) | (2) | 0 | 10 | 15 | (127) | 2 | 7 | 13 | | 14 |
Addback: Other Non Operating Expenses, Total | (3) | (4) | 0 | 0 | (0) | (0) | 2 | 1 | 2 | 1 | | (1) |
Addback: Depreciation & Amortization | 7 | 9 | 10 | 29 | 87 | 110 | 122 | 68 | 56 | 53 | | 50 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 82 | 1,569 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | (81) | (380) | 0 | 1 | 1 | (23) | | 5 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 2 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2) | 1 | 1 | | (1) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (0) | (0) | (5) | (14) | 0 | 0 | (39) | (34) | (27) | (29) | | (29) |
Adjusted EBITDA | 57 | 64 | 74 | 166 | 329 | 106 | (18) | 57 | 79 | 34 | | (2) |
% Margin | 23.6% | 24.6% | 19.6% | 22.4% | 26.5% | 11.4% | -2.2% | 5.3% | 6.7% | 2.9% | | -0.2% |
| | | | | | | | | | | | |
Adjusted EBIT | 49 | 55 | 64 | 138 | 242 | (5) | (140) | (11) | 23 | (19) | | (52) |
% Margin | 20.5% | 21.1% | 17.0% | 18.5% | 19.5% | -0.5% | -16.6% | -1.0% | 2.0% | -1.6% | | -4.2% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 45 | 51 | 61 | 129 | 198 | (1,204) | 56 | 29 | 46 | 19 | | (38) |
Addback: Unusual Items | 0 | (0) | (5) | (14) | 1 | 1,190 | (38) | (33) | (26) | (51) | | (25) |
Less: Tax Benefit of Unusual Items (26%) | (0) | 0 | 1 | 4 | (0) | (309) | 10 | 8 | 7 | 13 | | 7 |
Adjusted Net Income | 45 | 51 | 57 | 119 | 199 | (323) | 27 | 4 | 27 | (19) | | (57) |
% Margin | 18.6% | 19.6% | 15.1% | 16.0% | 16.0% | -34.9% | 3.2% | 0.4% | 2.3% | -1.6% | | -4.5% |